Emanuela Falaschetti is a Research Fellow in Clinical Trial Statistics at the Imperial Clinical Trial Unit (ICTU), School of Public Health. She is involved in all stages of clinical trials, from design to analysis and reporting. She graduated (MSc) in Statistics at Bologna University and she is Chartered statistician (CStat) member of the Royal Statistical Society. Before joining Imperial College she was Research Associate at the Department of Epidemiology and Public Health, University College London (UCL) from 1999 to 2009, working on the Heath Survey for England and Senior Research Associate at the Vascular Physiology Unit, Institute of Cardiovascular Science, UCL from 2009 to 2011, involved in different projects (cohort studies and interventional trials). Her main areas of research are in cardiovascular, metabolic and respiratory fields.
et al., 2022, The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial, Trials, Vol:23, ISSN:1745-6215
et al., 2022, Duodenal-jejunal bypass liner for the management of Type 2 diabetes and obesity: a multicenter randomized controlled trial, Annals of Surgery, Vol:275, ISSN:0003-4932, Pages:440-447
et al., 2022, Decision support system to evaluate ventilation in the acute respiratory distress syndrome (DeVENT study)-trial protocol, Trials, Vol:23, ISSN:1745-6215, Pages:1-18
et al., 2021, Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome (DeVENT study) – Trial Protocol, Trials, ISSN:1745-6215
et al., 2021, His-Optimized Pacing in Patients With a Long PR Interval, Narrow QRS and Heart Failure: Results of the Hope-hf Clinical Trial, LIPPINCOTT WILLIAMS & WILKINS, Pages:E587-E587, ISSN:0009-7322